A review of health utilities across conditions common in paediatric and adult populations

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Tarride, Jean Eric ^a,b   Burke, Natasha ^a,b   Bischof, Matthias ^a,b   Hopkins, Robert B ^a,b   Goeree, Linda ^a,b   Campbell, Kaitryn ^a,b   Xie, Feng ^a,b   O'Reilly, Daria ^a,b   Goeree, Ron ^a,b  

^a Programs for Assessment of Technology in Health PATH Research Institute   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ASTHMA; CANCER SURVIVAL; CANCER THERAPY; CHILD; CHRONIC DISEASE; COST UTILITY ANALYSIS; DISEASE CONTROL; DISEASE SEVERITY; EUROQOL 5DIMENSIONS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HEALTH UTILITIES INDEX; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NEOPLASM; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; QUALITY OF LIFE; REVIEW; SKIN DISEASE; STANDARD GAMBLE; TIME TRADE OFF; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; FEMALE; HEALTH SERVICES RESEARCH; MALE; METHODOLOGY; PEDIATRICS; QUALITY ADJUSTED LIFE YEAR;

ADULT; ASTHMA; CHILD; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; NEOPLASMS; PEDIATRICS; QUALITY-ADJUSTED LIFE YEARS; SKIN DISEASES;

EID: 77649136176     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-12     Document Type: Review

References (92)

1. Taylor R. Using health outcomes data to inform decision-making: government agency perspective. Pharmacoeconomics 2001, 19(Suppl 2):33-38. 10.2165/00019053-200119002-00006, 11700787.
2. Keren R, Pati S, Feudtner C. The generation gap: differences between children and adults pertinent to economic evaluations of health interventions. Pharmacoeconomics 2004, 22:71-81. 10.2165/00019053-200422020-00001, 14731049.
3. Paediatric Quality of Life. The development of a paediatric health related quality of life measure for use in economic evaluation: The Child Health Utility 9D (CHU 9D). 2009, The University of Sheffield., http://www.shef.ac.uk/scharr/sections/heds/mvh/paediatric
4. Griebsch I, Coast J, Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics 2005, 115:e600-e614. 10.1542/peds.2004-2127, 15867026.
5. Solans M, Pane S, Estrada MD, Serra-Sutton V, Berra S, Herdman M, et al. Health-Related Quality of Life Measurement in Children and Adolescents: A Systematic Review of Generic and Disease-Specific Instruments. Value Health 2008, 11:742-764. 10.1111/j.1524-4733.2007.00293.x, 18179668.
6. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004, 42:851-859. 10.1097/01.mlr.0000135827.18610.0d, 15319610.
7. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004, 13:873-884. 10.1002/hec.866, 15362179.
8. Hawthorne G. Assessing utility where short measures are required: development of the short Assessment of Quality of Life-8 (AQoL-8) instrument. Value Health 2009, 12:948-957. 10.1111/j.1524-4733.2009.00526.x, 19490558.
9. Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health 2006, 9:213-218. 10.1111/j.1524-4733.2006.00116.x, 16903990.
10. Mittmann N, Trakas K, Risebrough N, Liu BA. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics 1999, 15:369-376. 10.2165/00019053-199915040-00004, 10537955.
11. Eiser C, Morse R. A review of measures of quality of life for children with chronic illness. Arch Dis Child 2001, 84:205-211. 10.1136/adc.84.3.205, 1718699, 11207164.
12. Chiou CF, Weaver MR, Bell MA, Lee TA, Krieger JW. Development of the multi-attribute Pediatric Asthma Health Outcome Measure (PAHOM). Int J Qual Health Care 2005, 17:23-30. 10.1093/intqhc/mzh086, 15668307.
13. Mittmann N, Chan D, Trakas K, Risebrough N. Health utility attributes for chronic conditions. Dis Manag Health Outcomes 2001, 9:11-21.
14. Schultz SE, Kopec JA. Impact of chronic conditions. Health Rep 2003, 14:41-53.
15. Willems DC, Joore MA, Hendriks JJ, Wouters EF, Severens JL. Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial. Cost Eff Resour Alloc 2007, 5. Article Number: 10. Date of Publication: 27 July 2007., 10.1186/1478-7547-5-10, 2000864, 17662113.
16. Juniper EF, Guyatt GH, Feeny DH, Griffith LE, Ferrie PJ. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Eur Respir J 1997, 10:2285-2294. 10.1183/09031936.97.10102285, 9387955.
17. Aburuz S, Gamble J, Heaney LG. Assessment of impairment in health-related quality of life in patients with difficult asthma: psychometric performance of the Asthma Quality of Life Questionnaire. Respirology 2007, 12:227-233. 10.1111/j.1440-1843.2006.01020.x, 17298455.
18. Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998, 80:189-194.
19. Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001, 10:621-635. 10.1023/A:1013171831202, 11822795.
20. Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007, 120:396-402. 10.1016/j.jaci.2007.04.040, 17561244.
21. Flood EM, De CE, Mork A-C, Revicki DA. Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries. Health Qual Life Outcomes 2006, 4. Article Number: 51. Date of Publication: 15 Aug 2006..
22. Juniper EF, Norman GR, Cox FM, Roberts JN. Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001, 18:38-44. 10.1183/09031936.01.00088301, 11510803.
23. Ko Y, Coons SJ. Self-reported chronic conditions and EQ-5D index scores in the US adult population. Curr Med Res Opin 2006, 22:2065-2071. 10.1185/030079906X132622, 17031907.
24. Leidy KN, Chan KS, Coughlin C. Is the asthma quality of life questionnaire a useful measure for low-income asthmatics?. Am J Respir Crit Care Med 1998, 158:1082-1090.
25. Lloyd A, Price D, Brown R. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK. Primary Care Respiratory Journal 2007, 22-27. 10.3132/pcrj.2007.00002, 17297523.
26. Lloyd A, Doyle S, Dewilde S, Turk F. Preferences and utilities for the symptoms of moderate to severe allergic asthma. Eur J Health Econ 2008, 9:275-284. 10.1007/s10198-007-0075-0, 18038166.
27. Lubetkin EI, Jia H, Franks P, Gold MR. Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: Examining the EQ-5D in the U.S. general population. Qual Life Res 2005, 14:2187-2196. 10.1007/s11136-005-8028-5, 16328899.
28. McTaggart-Cowan HM, Marra CA, Yang Y, Brazier JE, Kopec JA, Fitzgerald JM, et al. The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res 2008, 17:453-462. 10.1007/s11136-008-9309-6, 18274882.
29. Moy ML, Fuhlbrigge AL, Blumenschein K, Chapman RH, Zillich AJ, Kuntz KM, et al. Association between preference-based health-related quality of life and asthma severity. Ann Allergy Asthma Immunol 2004, 92:329-334.
30. Nyman JA, Barleen NA, Dowd BE, Russell DW, Coons SJ, Sullivan PW. Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics. Med Care 2007, 45:618-628. 10.1097/MLR.0b013e31803dce05, 17571010.
31. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. A comparison of the responsiveness of different generic health status measures in patients with asthma. Qual Life Res 2003, 12:555-563. 10.1023/A:1025051829223, 13677500.
32. Polley L, Yaman N, Heaney L, Cardwell C, Murtagh E, Ramsey J, et al. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest 2008, 134:295-302. 10.1378/chest.07-0141, 18071022.
33. Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998, 114:998-1007. 10.1378/chest.114.4.998, 9792568.
34. Saarni SI, Harkanen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res 2006, 15:1403-1414. 10.1007/s11136-006-0020-1, 16960751.
35. Szende A, Svensson K, Stahl E, Meszaros A, Berta GY. Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. Pharmacoeconomics 2004, 22:537-547. 10.2165/00019053-200422080-00005, 15217309.
36. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005, 14:1523-1532. 10.1007/s11136-004-7713-0, 16110932.
37. Alessi D, Dama E, Barr R, Mosso ML, Maule M, Magnani C, et al. Health-related quality of life of long-term childhood cancer survivors: a population-based study from the Childhood Cancer Registry of Piedmont, Italy. Eur J Cancer 2007, 43:2545-2552. 10.1016/j.ejca.2007.07.026, 17869094.
38. Barr RD, Petrie C, Furlong W, Rothney M, Feeny D. Health-related quality of life during post-induction chemotherapy in children with acute lymphoblastic leukemia in remission: An influence of corticosteroid therapy. Int J Oncol 1997, 11:333-339.
39. Barr RD, Simpson T, Whitton A, Rush B, Furlong W, Feeny DH. Health-related quality of life in survivors of tumours of the central nervous system in childhood--a preference-based approach to measurement in a cross-sectional study. Eur J Cancer 1999, 35:248-255. 10.1016/S0959-8049(98)00366-9, 10448267.
40. Barr RD, Chalmers D, De PS, Furlong W, Weitzman S, Feeny D. Health-related quality of life in survivors of Wilms' tumor and advanced neuroblastoma: a cross-sectional study. J Clin Oncol 2000, 18:3280-3287.
41. Cardarelli C, Cereda C, Masiero L, Viscardi E, Faggin R, Laverda A, et al. Evaluation of health status and health-related quality of life in a cohort of Italian children following treatment for a primary brain tumor. Pediatr Blood Cancer 2006, 46:637-644. 10.1002/pbc.20480, 16421901.
42. Cox CL, Lensing S, Rai SN, Hinds P, Burghen E, Pui CH. Proxy assessment of quality of life in pediatric clinical trials: application of the Health Utilities Index 3. Qual Life Res 2005, 14:1045-1056. 10.1007/s11136-004-4714-y, 16041900.
43. Felder-Puig R, Frey E, Sonnleithner G, Feeny D, Gadner H, Barr RD, et al. German cross-cultural adaptation of the Health Utilities Index and its application to a sample of childhood cancer survivors. Eur J Pediatr 2000, 159:283-288. 10.1007/s004310050071, 10789935.
44. Fluchel M, Horsman JR, Furlong W, Castillo L, Alfonz Y, Barr RD. Self and proxy-reported health status and health-related quality of life in survivors of childhood cancer in Uruguay. Pediatr Blood Cancer 2008, 50:838-843. 10.1002/pbc.21299, 17635006.
45. Fu L, Talsma D, Baez F, Bonilla M, Moreno B, Ah-Chu M, et al. Measurement of health-related quality of life in survivors of cancer in childhood in Central America: feasibility, reliability, and validity. J Pediatr Hematol Oncol 2006, 28:331-341. 10.1097/00043426-200606000-00003, 16794499.
46. Glaser AW, Furlong W, Walker DA, Fielding K, Davies K, Feeny DH, et al. Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the U.K. Eur J Cancer 1999, 35:256-261. 10.1016/S0959-8049(98)00367-0, 10448268.
47. Grant J, Cranston A, Horsman J, Furlong W, Barr N, Findlay S, et al. Health status and health-related quality of life in adolescent survivors of cancer in childhood. J Adolesc Health 2006, 38:504-510. 10.1016/j.jadohealth.2005.08.002, 16635760.
48. Hinds PS, Burghen EA, Zhou Y, Zhang L, West N, Bashore L, et al. The Health Utilities Index 3 invalidated when completed by nurses for pediatric oncology patients. Cancer Nurs 2007, 30:169-177. 10.1097/01.NCC.0000270700.11425.4d, 17510579.
49. Kennedy CR, Leyland K. Comparison of screening instruments for disability and emotional/behavioral disorders with a generic measure of health-related quality of life in survivors of childhood brain tumors. Int J Cancer Suppl 1999, 12:106-111. 10.1002/(SICI)1097-0215(1999)83:12+<106::AID-IJC19>3.0.CO;2-T, 10679880.
50. Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, et al. Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys 2002, 53:533-542. 10.1016/S0360-3016(02)02828-6, 12062594.
51. Pogany L, Barr RD, Shaw A, Speechley KN, Barrera M, Maunsell E. Health status in survivors of cancer in childhood and adolescence. Qual Life Res 2006, 15:143-157. 10.1007/s11136-005-0198-7, 16411038.
52. Shimoda S, de CB, Horsman J, Furlong W, Lopes LF, Seber A, et al. Translation and cultural adaptation of Health Utilities Index (HUI) Mark 2 (HUI2) and Mark 3 (HUI3) with application to survivors of childhood cancer in Brazil. Qual Life Res 2005, 14:1407-1412. 10.1007/s11136-004-6127-3, 16047515.
53. Shimoda S, Horsman J, Furlong W, Barr R, de CB. Disability and health-related quality of life in long-term survivors of cancer in childhood in Brazil. J Pediatr Hematol Oncol 2008, 30:563-570. 10.1097/MPH.0b013e31816e231c, 18799931.
54. Sung L, Greenberg ML, Young NL, McLimont M, Ingber S, Rubenstein J, et al. Validity of a modified standard gamble elicited from parents of a hospital-based cohort of children. J Clin Epidemiol 2003, 56:848-855. 10.1016/S0895-4356(03)00160-4, 14505769.
55. Van Schaik CS, Barr RD, DePauw S, Furlong W, Feeny D. Assessment of health status and health-related quality of life in survivors of Hodgkin's disease in childhood. Int J Cancer Suppl 1999, 12:32-38. 10.1002/(SICI)1097-0215(1999)83:12+<32::AID-IJC7>3.0.CO;2-V, 10679868.
56. Wright MJ, Galea V, Barr RD. Self-perceptions of physical activity in survivors of acute lymphoblastic leukemia in childhood. Pediatr Exerc Sci 2003, 15:191-201.
57. Wright MJ, Galea V, Barr RD. Proficiency of balance in children and youth who have had acute lymphoblastic leukemia. Phys Ther 2005, 85:782-790.
58. Yaris N, Yavuz MN, Yavuz AA, Okten A. Assessment of quality of life in pediatric cancer patients at diagnosis and during therapy. Turkish Journal of Cancer 2001, 31:139-149.
59. Janse AJ, Uiterwaal CS, Gemke RJ, Kimpen JL, Sinnema G. A difference in perception of quality of life in chronically ill children was found between parents and pediatricians. J Clin Epidemiol 2005, 58:495-502. 10.1016/j.jclinepi.2004.09.010, 15845336.
60. Sung L, Young NL, Greenberg ML, McLimont M, Samanta T, Wong J, et al. Health-related quality of life (HRQL) scores reported from parents and their children with chronic illness differed depending on utility elicitation method. J Clin Epidemiol 2004, 57:1161-1166. 10.1016/j.jclinepi.2004.05.003, 15567632.
61. Brown GC, Brown MM, Sharma S, Brown H, Gozum M, Denton P. Quality of life associated with diabetes mellitus in an adult population. J Diabetes Complications 2000, 14:18-24. 10.1016/S1056-8727(00)00061-1, 10925062.
62. Chancellor J, Aballea S, Lawrence A, Sheldon R, Cure S, Plun-Favreau J, et al. Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens. Pharmacoeconomics 2008, 26:217-234. 10.2165/00019053-200826030-00005, 18282016.
63. Currie CJ, Morgan CL, Poole CD, Sharplin P, Lammert M, McEwan P. Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin 2006, 22:1523-1534. 10.1185/030079906X115757, 16870077.
64. Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, et al. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 2006, 49:2272-2280. 10.1007/s00125-006-0380-7, 16944094.
65. Hart HE, Bilo HJ, Redekop WK, Stolk RP, Assink JH, Meyboom-de JB. Quality of life of patients with type I diabetes mellitus. Qual Life Res 2003, 12:1089-1097. 10.1023/A:1026197119569, 14651426.
66. Hart HE, Redekop WK, Bilo HJ, Berg M, Jong BM. Change in perceived health and functioning over time in patients with type I diabetes mellitus. Qual Life Res 2005, 14:1-10. 10.1007/s11136-004-0782-2, 15789936.
67. Kiberd BA, Larson T. Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: a theoretical analysis. Transplantation 2000, 70:1121-1127. 10.1097/00007890-200010150-00027, 11045657.
68. Landy J, Stein J, Brown MM, Brown GC, Sharma S. Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus. Med Sci Monit 2002, 8:CR543-CR548.
69. Lee AJ, Morgan CL, Morrissey M, Wittrup-Jensen KU, Kennedy-Martin T, Currie CJ. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes. Diabet Med 2005, 22:1482-1486. 10.1111/j.1464-5491.2005.01657.x, 16241910.
70. Nordfeldt S, Jonsson D. Shortterm effects of severe hypoglycaemia in children and adolescents with type 1 diabetes. A cost-of-illness study. Acta Paediatr 2001, 90:137-142. 10.1080/080352501300049244, 11236041.
71. Supina AL, Feeny DH, Carroll LJ, Johnson JA. Misinterpretation with norm-based scoring of health status in adults with type 1 diabetes. Health & Quality of Life Outcomes 2006, 4. Article Number: 15. Date of Publication: 16 March 2006.
72. Bergstrom KG, Arambula K, Kimball AB. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis. Cutis 2003, 72:407-411.
73. Chen CL, Kuppermann M, Caughey AB, Zane LT. A community-based study of acne-related health preferences in adolescents. Arch Dermatol 2008, 144:988-994. 10.1001/archderm.144.8.988, 18711070.
74. Chen SC, Bayoumi AM, Soon SL, Aftergut K, Cruz P, Sexton SA, et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Invest Dermatol 2004, 9:160-168.
75. Khanna D, Ahmed M, Furst DE, Ginsburg SS, Park GS, Hornung R, et al. Health values of patients with systemic sclerosis. Arthritis & Rheumatism 2007, 57:86-93.
76. Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol 2000, 43:229-233. 10.1067/mjd.2000.105507, 10906643.
77. Littenberg B, Partilo S, Licata A, Kattan MW. Paper Standard Gamble: the reliability of a paper questionnaire to assess utility. Med Decis Making 2003, 23:480-488. 10.1177/0272989X03259817, 14672108.
78. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999, 141:1067-1075. 10.1046/j.1365-2133.1999.03207.x, 10606854.
79. Revicki D, Willian MK, Saurat JH, Papp KA, Ortonne JP, Sexton C, et al. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol 2008, 158:549-557. 10.1111/j.1365-2133.2007.08236.x, 18047521.
80. Schiffner R, Brunnberg S, Hohenleutner U, Stolz W, Landthaler M. Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains. Br J Dermatol 2002, 146:440-447. 10.1046/j.1365-2133.2002.04613.x, 11952544.
81. Schiffner R, Schiffner-Rohe J, Gerstenhauer M, Hofstadter F, Landthaler M, Stolz W. Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients?. Br J Dermatol 2003, 148:1153-1160. 10.1046/j.1365-2133.2003.05156.x, 12828743.
82. Schmitt J, Meurer M, Klon M, Frick KD. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol 2008, 158:351-359.
83. Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health & Quality of Life Outcomes 2006, 4. Article Number: 71. Date of Publication: 27 September 2006..
84. Shikiar R, Heffernan M, Langley RG, Willian MK, Okun MM, Revicki DA. Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial. J Dermatolog Treat 2007, 18:25-31. 10.1080/09546630601121060, 17365264.
85. Stevens KJ, Brazier JE, McKenna SP, Doward LC, Cork MJ. The development of a preference-based measure of health in children with atopic dermatitis. Br J Dermatol 2005, 153:372-377. 10.1111/j.1365-2133.2005.06736.x, 16086752.
86. Stratton RJ, Wilson H, Black CM. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology (Oxford) 2001, 40:84-88. 10.1093/rheumatology/40.1.84, 11157146.
87. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002, 47:512-518. 10.1067/mjd.2002.122755, 12271293.
88. Zug KA, Littenberg B, Baughman RD, Kneeland T, Nease RF, Sumner W, et al. Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Arch Dermatol 1995, 131:561-568. 10.1001/archderm.131.5.561, 7741543.
89. Brazier J. Valuing health States for use in cost-effectiveness analysis. Pharmacoeconomics 2008, 26:769-779. 10.2165/00019053-200826090-00007, 18767897.
90. Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ 2003, 12:697-702. 10.1002/hec.775, 12898666.
91. Pal DK. Quality of life assessment in children: a review of conceptual and methodological issues in multidimensional health status measures. J Epidemiol Community Health 1996, 50:391-396. 10.1136/jech.50.4.391, 1060307, 8882220.
92. Murphy BA, Ridner S, Wells N, Dietrich M. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol 2007, 62:251-267. 10.1016/j.critrevonc.2006.07.005, 17408963.